Abstract
Vascular Endothelial Growth Factor, an endothelial cell specific growth factor, is a glycoprotein that exerts its effect through cell surface receptor dependent signaling events. Apart from glycosylation, a key posttranslational modification of VEGF involves polyADP ribosylation. While glycosylation is critical in its secretion, PAR modification is not critical for its secretion as evidenced by absence of any significant effect of 3-aminobenzamide, an inhibitor of PAR modification on the level of VEGF secreted into the medium by cells in culture. However, the PAR modification appeared to be critical in its angiogenic potential as evidenced by a reciprocal relation between the level of PAR modification and the angiogenic effect of VEGF in CAM assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamis AP, Yeo KT et al (1994) Increased vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy. Am J Opthalmol 118:445–450
Aiello LP, King G et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487
Baldwin ME, Roufail S, Halford MM et al (2001) Multiple forms of mouse vascular endothelial growth factor D are generated by RNA splicing and proteolysis. J Biol Chem 276:44307–44314
Barleon B, Siemeister G, Martiny-Baron G et al (1997) Vascular endothelial growth factor upregulates its receptor fms like tyrosine kinase (FLT-1). Cancer Res 57:5421–5425
Brandner B, Kurkela B, Vihko P, Kungl AJ (2006) Investigating the effect of VEGF glycosylation on GAG binding and protein folding. Biochem Biophys Res Commun 3:836–839
Cao Y (2005) Tumor angiogenesis and therapy. Biomed Pharmacother 59:S340–343
Carmeliet P, Andras N, Ferreira V, Breier G et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439
Chade AR, Bentley HD, Zhu X et al (2004) Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. Am Soc Nephrol 15:1816–1825
Chambon P, Weill JD, Mandel IL (1963) Nicotinamide mononucleotide activation of a new DNA- dependent polyadenylic acid synthesizing enzyme. Biochem Biophys Res Commun 11:39–43
Chua CC, Hamdy RC, Chua BH (1998) Upregulation of Vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25:891–897
D’Amours D, Desnoyers S, D’Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. J Biochem 342(2):249–268
Davidovic L, Vodenicharov M, Affar EB, Poirier GG (2001) Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 268:7–13
Dumount DJ, Fong GH, Puri MC et al (1995) Vascularization of the mouse embryo, a study of FLK-1, tck, tie and vascular EGF expression during development. Dev Dyn 203:80–92
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039
Ema M, Taya S, Yokotani N et al (1997) A novel bHLH –PAS factor with close sequence similarity to hypoxia inducible factor 1α regulates VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94:4273–4278
Eola KK, Lymboussaki A, Taira S et al (1996) VEGF C receptor binding and pattern of expression with VEGFR 3 suggests a role in lymphatic vascular development. Development 122:3629–3837
Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127–137
Ferrara N, Houck KA, Jakeman LB et al (1991) Vascular endothelial growth factor family of polypeptides. Cell Biochem 47:211–218
Ferrara N, Moore MW, Dowd M, Lu L, Hillan KJ et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of VEGF gene. Nature 380:439–442
Ferrara N, Gerber HP, Le Couter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27–31
Gluzman-Poltorak Z, Cohen T, Herzog Y et al (2000) Neuropilin-2 is a receptor for the VEGF forms VEGF145 and VEGF165. J Biol Chem 275:18040–18045
Gnarra JR (1996) Post translational regulation of vascular endothelial growth factor mRNA by the product of VHL tumor suppressor gene. Prac Natl Acad Sci USA 20:10589–10594
Hassa PO, Hottiger MO (2008) The diverse biological roles of mammalian PARPs, a small but powerful family of ply-ADP-ribose polymerases. Front Biosci 13:3046–3082
Hassa PO, Haenni SS, Elser M, Hottiger MO (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70: 789–829
Hermann J, Lerman LO, Mukhopadhyay D et al (2006) Angiogenesis in atherogenesis. Thromb Vasc Biol 26:1948–1957
Houck KA, Ferrara N, Winer J et al (1991) The vascular endothelial growth factor family identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endrocrinol 5:1806–1814
Huang LE, Bunn HF (2003) Hypoxia inducible factor and its biomedical relevance. J Biol Chem 278:19575–19578
Joukov V, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF C is a ligand for the FLT 4(VEGFR-3) and KDR(VEGFR-2) receptor kinases. EMBO J 15:290–298
Keck PJ, Connolly HSD et al (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312
Kim JK, Ferrara N (1993) Inhibition of vascular endothelial growth factor induced angiogenesis supresses tumor growth in vivo. Nature 362:841–844
Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: ‘PAR- laying’ NAD+ into a nuclear signal. Genes Dev 19:1951–1967
Kumar VB, Viji RI, Kiran MS, Sudhakaran PR (2007) Endothelial cell response to lactate: implications of PAR modification of VEGF. J Cell Physiol 211(2):477–485
Lee J, Gray A, Yuan J et al (1996) Vascular endothelial growth factor related protein: a ligand and specific activator of the tyrosine kinase receptor flt-4. Proc Natl Acad Sci USA 93:1988–1992
Leung DW, Cachianes G, Kuang WJ et al (1989) Vascular endothelial growth factor is a secreted angiogenesis mitogen. Science 246:1306–1309
Levy NS, Chung S, Furneaux H et al (1998) Hypoxia stabilization of vascular endothelial growth factor mRNA by the RNA binding protein HuR. J Biol Chem 273:6417–6423
Liu Y, Cox SR, Morita T, Kourembana S (1995) Hypoxia regulates VEGF gene expression in endothelial cells, identification of a 5′ enhancer. Circ Res 77:638–643
Maglione D, Guerriero V, Viglietto G et al (1991) Isolation of human placenta cDNA coding for a protein related to vascular permeability factor. Proc Natl Acad Sci USA 88:9267–9271
Mandriota SJ, Seghezzi G, Vassalli JD et al (1995) Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270:9709–9716
Minchinko A, Salieda I, Bauer T, Caro J (1994) Hypoxia regulatory elements of human VEGF gene. Cell Mol Biol Res 40:35–39
Modlich U, Kaup J, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771–780
Neufeld G, Tessler S, Gitay-Goren H et al (1994) Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5:89–97
Olofsson B, Pajusola K, von Euler G et al (1996) Genomic organization of the mouse and human genes for vascular endothelial growth factor B and characterization of a second splice isoforms. J Biol Chem 271:19310–19317
Park JE, Killer GA, Ferrrara N (1993) The vascular endothelial growth factor isoforms: differential deposition into sub endothelial extra cellular matrix and bioavailability of extracellular matrix bound VEGF. Mol Biol Cell 4:1317–1326
Pepper MS, Ferrara N, Orci L, Montesano R (1991) VEGF induces plasminogen activators and plasminogen activator inhibitor 1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902–906
Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824–831
Peretz D, Gitay-Goren H, Safran H et al (1992) Glycosylation of VEGF is not required for its mitogenic activity. Biochem Biophys Res Commun 182(3):1340–1347
Plouet J, Schilling J, Gos Podarowicz D (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8(12):3801–3806
Ruf A, Mennissier de Murcia J, de Murcia G, Schulz GE (1996) Structure of the catalytic fragment of poly(ADP-ribose) polymerase from chicken. Proc Natl Acad Sci USA 93:7481–7485
Senger DR, Galli SJ, dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promote accumulation of ascites fluid. Science 219:983–985
Stacker SA, Stenvers K, Caesar C et al (1999) Biosynthesis of vascular endothelial growth factor D involves proteolytic processing which generates non covalent homodimers. J Biol Chem 274:32127–32136
Stein I (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18(6):3112–3119
Tischler E, Abraham JA (1991) The human gene for vascular endothelial growth factor, multiple protein forms are encoded through alternative splicing of RNA. J Biol Chem 226:11947–11954
Tulin A, Spradling A (2003) Chromatin loosening by poly(ADP) ribose polymerase (PARP) at Drosophila puff loci. Science 299:560–562
Viji RI, Sameerkumar VB, Kiran MS, Sudhakaran PR (2008) Angiogenic response of endothelial cells to heparin-binding domain of fibronectin. Int J Biochem Cell Biol 40(2):215–226
Xiong M, Elson G, Legarda D, Leibovich SL (1998) Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate and inducible nitric oxide synthase pathway. Am J Pathol 153:587–598
Acknowledgment
The authors acknowledge support from University Grants Commission and Kerala State Council for Science, Technology, and Environment.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Binu, S., Soumya, S.J., Kumar, V.B.S., Sudhakaran, P.R. (2012). Poly-ADP-Ribosylation of Vascular Endothelial Growth Factor and Its Implications on Angiogenesis. In: Sudhakaran, P., Surolia, A. (eds) Biochemical Roles of Eukaryotic Cell Surface Macromolecules. Advances in Experimental Medicine and Biology, vol 749. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3381-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3381-1_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3380-4
Online ISBN: 978-1-4614-3381-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)